Phosphodiesterase-4D Knockdown in the Prefrontal Cortex Alleviates Memory Deficits and Synaptic Failure in Mouse Model of Alzheimer’s Disease
Phosphodiesterase 4 (PDE4)-dependent cAMP signaling plays a crucial role in cognitive impairment associated with Alzheimer’s disease (AD). However, whether inhibition of PDE4 subtypes or their splice variants in the prefrontal cortex positively regulates synaptic plasticity and antioxidative stress,...
Main Authors: | Yongchuan Shi, Jinpeng Lv, Ling Chen, Guojun Luo, Mengjia Tao, Jianchun Pan, Xiaoxiong Hu, Jianwen Sheng, Shanjin Zhang, Min Zhou, Huizhen Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.722580/full |
Similar Items
-
Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
by: Fabiha Zaheen Khan, et al.
Published: (2022-07-01) -
Genetic Association of Phosphodiesterases With Human Cognitive Performance
by: Mark E. Gurney
Published: (2019-02-01) -
Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?
by: Moussa B.H. Youdim
Published: (2010-10-01) -
The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson’s disease mouse models
by: Yu-Young Lee, et al.
Published: (2019-12-01) -
Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue
by: Laura Ponsaerts, et al.
Published: (2021-06-01)